Language: Spanish
References: 45
Page: 87-128
PDF size: 649.55 Kb.

ABSTRACT

No abstract

REFERENCES

1. Rizvi F, Mackey R, Barrett T, McKenna P, Geary M. Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 2004;111:495-8.

2. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland 2003-05. BJOG 2007;114:1388-96.

3. Joseph KS, Rouleau J, Kramer MS, Young DC, et al. Maternal health study group of the Canadian Perinatal Surveillance System, investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007;114:751-9.

4. Winter C, Macfarlane A, Deneux-Tharaux C, Zhang WH, et al. Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG 2007;114:845-54.

5. Deneux-Tharaux C, Dreyfus M, Goffinet F, Lansac J, et al. Prevention and early management of immediate postpartum haemorrhage: Policies in six perinatal networks in France. J Gynecol Obstet Biol Reprod 2008;37:237-45.

6. Althabe F, Buekens P, Bergel E, Belizan JM, et al. A behavioral intervention to improve obstetrical care. N Engl J Med 2008;358:1929-40.

7. Schuurmans N, MacKinnon C, Lane C, Etches D. Prevention and management of postpartum haemorrhage, SOGC Clinical Practice Guidelines. Vol. 88. Ottawa: Society of Obstetricians and Gynaecologists of Canada, 2000. [en línea]. Dirección URL: .

8. Marchant S, Alexander J, Thomas P, Garda J, et al. Risk factors for hospital admission related to excessive and/or prolonged postpartum vaginal blood loss after the first 24 h following childbirth. Paediatr Perinat Epidemial 2006:20:392-402.

9. Romero GG, Espitia VA, Ponce PL, Huerta VL. Risk factors of maternal death in Mexico. Birth 2007;34:21-25.

10. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gulmezoglu M. Patrones de control prenatal de rutina para embarazos de bajo riesgo. Biblioteca Cochrane Plus, 2008(2). [en línea]. Dirección URL: .

11. Alexander J, Thomas P, Sanghera J. Tratamientos para la hemorragia posparto secundaria. Biblioteca Cochrane Plus, 2007(4). [en línea]. Dirección URL: .

12. Bouvier-Colle MH, Ould EI, Joud D, Varnoux N, et al. Evaluation of the quality of care for severe obstetrical haemorrhage in three French regions. BJOG 2001;108:898-903.

13. Bulger EM, Jurkovich GJ, Nathens AB, Copass MK, et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg 2008;143:139-48.

14. Johnson W, Swiatkowski SA. Scientific aspects of supplying blood to distant military theaters. Curr Opin Hematol 2007;14:694-9.

15. Martel MJ, Saskatoon SK. Hemorragic shock. J Obstet Gynaecol Can 2002;24:504-11.

16. British Committee for Standards in Haematology, Stainsby D, MacLennan S, Thomas D, et al. Guidelines on the management of massive blood loss. Br J Haematol 2006;135:634-41.

17. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006;113:919-24.

18. Buckland SS, Homer CS. Estimating blood loss after birth: using simulated clinical examples. Women Birth 2007;20:85-88.

19. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG 2007;114:356-61.

20. Utwick A, Carvalho B. The effect of colloid and crystalloid preloading on thromboelastography prior to cesarean delivery. Can J Anaesth 2007;54:190-5.

21. Repine TB, Perkins JG, Kauvar DS, Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma 2006;60(Suppl. 6):S59-69.

22. Norma Oficial Mexicana NOM-003-SSA2, 1993 para la disposición de sangre humana y sus componentes con fines terapéuticos.

23. Tinmouth AT, McIntyre LA, Fowler RA. Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. CMAJ 2008;178:49-57.

24. Samama CM, Djoudi R, Lecompte T, Nathan N, et al. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003. Minerva Anestesiol 2006;72:47-52.

25. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006;60(Suppl. 6):S51-8.

26. O’Shaughnessy DF, Atterbury C, Bolton-Maggs P, Murphy M, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11-28.

27. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg 2007;31:1055-64.

28. Khan H, Belsher J, Yilmaz M, Afessa B, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients, Chest 2007;131:1308-14.

29. Middelburg RA, van Stein 0, Briet E, van der Bom JG. The role of donor in the patogenesis of transfusion related acute lung injury: a systematic review. Transfusion 2008;48:2167-76.

30. Anjaria OJ, Mohr AM, Deitch EA, Haemorrhagic shock therapy, Expert Opin Pharmacother 2008;9:901-11.

31. Assessment Program. Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients. Technology Evaluation Center 2006;21(10). [en línea]. Dirección URL: .

32. Welsh A, McLintock C, Gatt S, Somerset O, et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage, Aust N Z J Obstet Gynaecol 2008;48:12-26.

33. McMorrow RC, Ryan SM, Blunnie WP, Bowen M, et al. Use of recombinant factor Vila in massive post-partum haemorrhage, Eur J Anaesthesiol 2008;25:293-8.

34. Henry DA, Carless PA, Moxey AJ, O’Conell O, et al. Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion. Cochrane Database Syst Rev 2007;4:CD001886.

35. Davies L, Brown TJU, Haynes S, Payne K, et al. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogenic blood transfusion: a systematic review and economic model. Health Technol Assess 2006;10:1-210.

36. Langenbach C. Misoprostol in preventing postpartum hemorrhage: a meta-analysis. Int J Gynaecol Obstet 2006;92:10-18.

37. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007;(1):CD003249.

38. Saito K, Haruki A, Ishikawa H, Takahashi I, et al. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage. J Obstet Gynaecol Res 2007;33:254-8.

39. LiabsuetrakulT, Choobun T, Peeyananjarassri K, Islam OM. Uso profiláctico de alcaloides del cornezuelo de centeno en la etapa expulsiva del trabajo de parto (Cochrane Review). Biblioteca Cochrane Plus, 2007(4). [en línea]. Dirección URL: .

40. Balki M, Dhumne S, Kasodekar S, Kingdom J, et al. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest. BJOG 2008;115:579-84.

41. Magann EF, Doherty DA, Briery CM, Niederhauser A, et al. Obstetric characteristics for a prolonged third stage of labor and risk for postpartum hemorrhage. Gynecol Obstet Invest 2008;65:201-5.

42. Carroli G, Bergel E. Inyección en la vena umbilical para el tratamiento de la placenta retenida (Cochrane Review). Biblioteca Cochrane Plus, 2007(4). [en línea]. Dirección URL: .

43. Hensleigh PA. Anti-shock garment provides resuscitation and haemostasis for obstetric haemorrhage, BJOG 2002;109:1377-84.

44. Miller S, Hamza S, Bray EH, Lester F, et al. First aid for obstetric haemorrhage: the pilot study of the non-pneumatic anti-shock garment in Egypt. BJOG 2006;113:424-9.

45. Brees C, Hensleigh PA, Miller S, Pelligra R. A non-inflatable anti-shock garment for obstetric hemorrhage. Int J Gynaecol Obstet 2004;87:119-24.